Daiichi Sankyo will remain dominant in ADC market for oncology treatments: GlobalData EP News Bureau Aug 7, 2023 By 2029, the global market for ADC therapies in oncology is expected to be worth more than $36 billion
Glenmark reduces cost of Trastuzumab treatment in India EP News Bureau Jun 15, 2023 A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country
